Health
GLP-1 Drugs Show Personalized Potential
A study suggests that GLP-1 drugs could be personalized for individual patients, leading to greater cardiometabolic improvements. The research focuses on higher-dosage GLP-1 agonists.
Coverage timeline — 1 article
The Hill
The higher-dosage GLP-1 agonists largely engendered greater cardiometabolic improvements.
2026-07-31 10:44 UTC